We are live on
!
Find out more
AEPBI
AH Equity Partners Bio II Portfolio holdings
AUM
$144M
1-Year Est. Return
54.61%
This Fund
S&P 500
This Quarter
Est. Return
-31.09%
1 Year Est. Return
-54.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$18.5M
(-9.6%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.63% |
Similar funds
JAMH
SFI
MPU
HGM
EVC
SP
SC
SCM
AH Equity Partners Bio II's Q1 2022 Portfolio in Review
As of Q1 2022, AH Equity Partners Bio II held 4 positions worth $174M, down 9.6% from $192M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 0%. AH Equity Partners Bio II opened no new positions and made no exits, leaving the 4-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier.
- AH Equity Partners Bio II's ten largest holdings make up 100% of its $174M portfolio in Q1 2022.
- AH Equity Partners Bio II opened 0 new positions and closed 0 in Q1 2022.
- AH Equity Partners Bio II's portfolio value fell 9.6% quarter-over-quarter to $174M.
Based on AH Equity Partners Bio II's 13F filing for Q1 2022, filed 16 May 2022.